Estimation of secondary cancer risk after radiotherapy in high-risk prostate cancer patients with pelvic irradiation

被引:10
|
作者
Haciislamoglu, Emel [1 ]
Gungor, Gorkem [2 ]
Aydin, Gokhan [2 ]
Canyilmaz, Emine [1 ]
Guler, Ozan Cem [3 ]
Zengin, Ahmet Yasar [4 ]
Yenice, Kamil Mehmet [5 ]
机构
[1] Karadeniz Tech Univ, Fac Med, Dept Radiat Oncol, Trabzon, Turkey
[2] Acibadem Univ, Dept Radiat Oncol, Istanbul, Turkey
[3] Baskent Univ, Fac Med, Dept Radiat Oncol, Adana, Turkey
[4] Kanuni Res & Educ Hosp, Dept Radiat Oncol, Trabzon, Turkey
[5] Univ Chicago Med, Dept Radiat & Cellular Oncol, Chicago, IL USA
来源
关键词
flattening filter free (FFF); prostate cancer; radiation-induced secondary cancer; radiotherapy (RT); volumetric modulated arc therapy (VMAT); INTENSITY-MODULATED RADIOTHERAPY; ATOMIC-BOMB SURVIVORS; RADIATION-INDUCED CANCER; OF-FIELD PHOTON; CALCULATED RISK; SOLID CANCER; ARC THERAPY; FLATTENING FILTER; 2ND CANCERS; EXPOSURE;
D O I
10.1002/acm2.12972
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
We aimed to estimate the risk of secondary cancer after radiotherapy (RT) in high-risk prostate cancer (HRPC) patients with pelvic irradiation. Computed tomography data of five biopsy-proven HRPC patients were selected for this study. Two different planning target volumes (PTV(1)and PTV2) were contoured for each patient. The PTV(1)included the prostate, seminal vesicles, and pelvic lymphatics, while the PTV(2)included only the prostate and seminal vesicles. The prescribed dose was 54 Gy for the PTV(1)with a sequential boost (24 Gy for the PTV2). Intensity-modulated RT (IMRT) and volumetric modulated arc therapy (VMAT) techniques were used to generate treatment plans with 6 and 10 MV photon energies with the flattening filter (FF) or flattening filter-free (FFF) irradiation mode. The excess absolute risks (EARs) were calculated and compared for the bladder, rectum, pelvic bone, and soft tissue based on the linear-exponential, plateau, full mechanistic, and specific mechanistic sarcoma dose-response model. According to the models, all treatment plans resulted in similar risks of secondary bladder or rectal cancer and pelvic bone or soft tissue sarcoma except for the estimated risk of the bladder according to the full mechanistic model using IMRT((6MV;FF))technique compared with VMAT techniques with FFF options. The overall estimation of EAR indicated that the radiation-induced cancer risk due to RT in HRPC was lower for bladder than the rectum. EAR values ranged from 1.47 to 5.82 for bladder and 6.36 to 7.94 for rectum, depending on the dose-response models used. The absolute risks of the secondary pelvic bone and soft tissue sarcoma were small for the plans examined. We theoretically predicted the radiation-induced secondary cancer risk in HRPC patients with pelvic irradiation. Nevertheless, prospective clinical trials, with larger patient cohorts with a long-term follow-up, are needed to validate these model predictions.
引用
收藏
页码:82 / 89
页数:8
相关论文
共 50 条
  • [1] Pelvic proton radiotherapy for high-risk prostate cancer
    Chera, B. S.
    Vargas, C.
    Flampouri, S.
    Morris, C. G.
    Yeung, D.
    Olivier, K.
    Duvvuri, S.
    Li, Z.
    Mendenhall, N. P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S326 - S326
  • [2] Radiotherapy after prostatectomy in high-risk prostate cancer
    Roviello, G.
    Villari, D.
    Nesi, G.
    Detti, B.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (11): : 2139 - 2140
  • [3] Radiotherapy for high-risk prostate cancer
    Jahan J. Mohiuddin
    Brock R. Baker
    Ronald C. Chen
    Nature Reviews Urology, 2015, 12 : 145 - 154
  • [4] Radiotherapy for high-risk prostate cancer
    Mohiuddin, Jahan J.
    Baker, Brock R.
    Chen, Ronald C.
    NATURE REVIEWS UROLOGY, 2015, 12 (03) : 145 - 154
  • [5] DOSIMETRIC STUDY OF PELVIC PROTON RADIOTHERAPY FOR HIGH-RISK PROSTATE CANCER
    Chera, Bhishamjit S.
    Vargas, Carlos
    Morris, Christopher G.
    Louis, Debbie
    Flampouri, Stella
    Yeung, Daniel
    Duvvuri, Srividya
    Li, Zuofeng
    Mendenhall, Nancy Price
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (04): : 994 - 1002
  • [6] Radiotherapy and hormone therapy in patients with high-risk prostate cancer
    Nature Clinical Practice Urology, 2008, 5 (1): : 4 - 4
  • [7] WHOLE PELVIS RADIOTHERAPY IN PATIENTS WITH HIGH-RISK PROSTATE CANCER
    Spagnoletti, Girolamo
    Marchese, Rita
    Leo, Anna Maria
    Nardella, Grazia
    Piserchia, Maria
    Rignanese, Raffaella
    Bove, Giuseppe
    ANTICANCER RESEARCH, 2012, 32 (05) : 1925 - 1925
  • [8] Radiotherapy and hormone therapy in patients with high-risk prostate cancer
    Nature Clinical Practice Oncology, 2008, 5 (1): : 8 - 8
  • [9] Necessity and extent of pelvic radiotherapy in cN0 high-risk prostate cancer patients
    Isebaert, S.
    Dirix, P.
    Tosco, L.
    Janssen, P.
    Joniau, S.
    Lerut, E.
    Van den Bergh, L.
    Oyen, R.
    Van Poppel, H.
    Haustermans, K.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S117 - S118
  • [10] Postoperative radiotherapy for high-risk prostate cancer
    Haines, Ian
    LANCET, 2013, 381 (9872): : 1093 - 1093